VeriMomr-clostridium histolyticum collagenase g hamilelikte güvenli mi?
No harmonised reproductive hazard (H360/H361) for C. histolyticum collagenase was found. Clinical and regulatory sources (drug monographs / FDA/EMA product information and PubMed clinical literature) describe local enzymatic effects and injection-site risks but do not report developmental or teratogenic effects; no CIR or SCCS safety assessment for cosmetic topical use was identified. Sources: clinical drug monographs and PubMed summaries show use as an injected medical product without reproductive classification. ([drugs.com](https://www.drugs.com/monograph/collagenase-clostridium-histolyticum.html?utm_source=openai))
Related ingredients
Frequently asked questions
- r-clostridium histolyticum collagenase g hamilelikte güvenli mi?
- No harmonised reproductive hazard (H360/H361) for C. histolyticum collagenase was found. Clinical and regulatory sources (drug monographs / FDA/EMA product information and PubMed clinical literature) describe local enzymatic effects and injection-site risks but do not report developmental or teratogenic effects; no CIR or SCCS safety assessment for cosmetic topical use was identified. Sources: clinical drug monographs and PubMed summaries show use as an injected medical product without reproductive classification. ([drugs.com](https://www.drugs.com/monograph/collagenase-clostridium-histolyticum.html?utm_source=openai))
- r-clostridium histolyticum collagenase g emzirirken güvenli mi?
- No evidence in peer‑reviewed literature or regulatory monographs of effects on lactation or transfer in breastmilk. As a high‑molecular‑weight protein/enzyme used in injectable formulations, systemic exposure in cosmetic topical use is expected to be negligible; no studies showing breastmilk transfer or lactation toxicity were located. ([drugs.com](https://www.drugs.com/monograph/collagenase-clostridium-histolyticum.html?utm_source=openai))
- r-clostridium histolyticum collagenase g bebek cildi için güvenli mi?
- Hazard and mechanism: no infant‑specific reproductive or developmental toxicity evidence was found (h=0, m=0). Exposure: dermal absorption of large enzymes is expected to be negligible in adults (e=0) but, per your calibration rule, infant/0–3 y skin barrier immaturity increases exposure rating by +1 to e=1 if the ingredient has measurable absorption potential. Enzyme products and SDSs emphasise respiratory sensitisation risk (inhalation) rather than dermal systemic toxicity. No baby‑specific studies located. ([sigmaaldrich.com](https://www.sigmaaldrich.com/catalog/product/roche/collhro?utm_source=openai))
- VeriMom r-clostridium histolyticum collagenase g nasıl puanlıyor?
- VeriMom r-clostridium histolyticum collagenase g'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte r-clostridium histolyticum collagenase g yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.